Sublethal doses of anthrax lethal toxin on the suppression of macrophage phagocytosis

PLoS ONE

Volumn 5, Issue 12, 2010, Pages 1-10

  Kau, Jyh Hwa ^a   Sun, Der Shan ^b   Huang, Hsuan Shun ^b   Lien, Te Sheng ^b   Huang, Hsin Hsien ^b   Lin, Hung Chi ^a   Chang, Hsin Hou ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; BACTERIAL ANTIGEN; BACTERIAL TOXIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACTEREMIA; BACTERIAL CLEARANCE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME REPRESSION; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; LD 50; MACROPHAGE FUNCTION; MALE; MORTALITY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; SPLEEN CELL; ANIMAL; BACILLUS ANTHRACIS; BIOLOGICAL MODEL; C57BL MOUSE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; LEUKOCYTE; MACROPHAGE; METABOLISM; METHODOLOGY; MICROBIOLOGY; MONONUCLEAR CELL; SEPSIS;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); MUS;

ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; MAP KINASE KINASE 1; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PHAGOCYTOSIS; SEPSIS;

EID: 78650733768     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014289     Document Type: Article

References (51)

1. Dixon TC, Meselson M, Guillemin J, Hanna PC (1999) Anthrax. N Engl J Med 341: 815-826.
2. Collier RJ, Young JA (2003) Anthrax toxin. Annu Rev Cell Dev Biol 19: 45-70.
3. Moayeri M, Leppla SH (2004) The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol 7: 19-24.
4. Abrami L, Reig N, van der Goot FG (2005) Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol 13: 72-78.
5. Fukao T (2004) Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. Lancet Infect Dis 4: 166-170.
6. Pezard C, Berche P, Mock M (1991) Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 59: 3472-3477.
7. Pezard C, Duflot E, Mock M (1993) Construction of Bacillus anthracis mutant strains producing a single toxin component. J Gen Microbiol 139(Pt 10): 2459-2463.
8. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, et al. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280: 734-737.
9. Vitale G, Pellizzari R, Recchi C, Napolitani G, Mock M, et al. (1998) Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun 248: 706-711.
10. Turk BE (2007) Manipulation of host signalling pathways by anthrax toxins. Biochem J 402: 405-417.
11. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
12. Crawford MA, Aylott CV, Bourdeau RW, Bokoch GM (2006) Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol 176: 7557-7565.
13. Park JM, Greten FR, Li ZW, Karin M (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297: 2048-2051.
14. During RL, Li W, Hao B, Koenig JM, Stephens DS, et al. (2005) Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis 192: 837-845.
15. Drysdale M, Heninger S, Hutt J, Chen Y, Lyons CR, et al. (2005) Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. Embo J 24: 221-227.
16. Buck M, Chojkier M (2007) C/EBPbeta phosphorylation rescues macrophage dysfunction and apoptosis induced by anthrax lethal toxin. Am J Physiol Cell Physiol 293: C1788-1796.
17. Tournier JN, Rossi Paccani S, Quesnel-Hellmann A, Baldari CT (2009) Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol Aspects Med 30: 456-466.
18. Kau JH, Lin CG, Huang HH, Hsu HL, Chen KC, et al. (2002) Calyculin A Sensitive Protein Phosphatase Is Required for Bacillus anthracis Lethal Toxin Induced Cytotoxicity. Curr Microbiol 44: 106-111.
19. Tonello F, Montecucco C (2009) The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity. Mol Aspects Med 30: 431-438.
20. Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, et al. (1998) Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol 161: 5681-5686.
21. Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, et al. (2004) Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol 76: 994-1001.
22. Mandell GL (1973) Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest 52: 1673-1679.
23. Vaudaux P, Waldvogel FA (1979) Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. Antimicrob Agents Chemother 16: 743-749.
24. Isberg RR, Voorhis DL, Falkow S (1987) Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 50: 769-778.
25. Chang HH, Shih KN, Lo SJ (2000) Receptor-mediated endocytosis as a selection force to enrich bacteria expressing rhodostomin on their surface. J Biomed Sci 7: 42-50.
26. Kau JH, Sun DS, Huang HH, Wong MS, Lin HC, et al. (2009) Role of visible light-activated photocatalyst on the reduction of anthrax spore-induced mortality in mice. PLoS ONE 4: e4167.
27. Mabry R, Brasky K, Geiger R, Carrion R, Jr., Hubbard GB, et al. (2006) Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol 13: 671-677.
28. Groves E, Dart AE, Covarelli V, Caron E (2008) Molecular mechanisms of phagocytic uptake in mammalian cells. Cell Mol Life Sci 65: 1957-1976.
29. Coombes BK, Valdez Y, Finlay BB (2004) Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses. Curr Biol 14: R856-867.
30. Pullikuth AK, Catling AD (2007) Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell Signal 19: 1621-1632.
31. During RL, Gibson BG, Li W, Bishai EA, Sidhu GS, et al. (2007) Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation. Embo J 26: 2240-2250.
32. Cui X, Li Y, Li X, Haley M, Moayeri M, et al. (2006) Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival. J Infect Dis 193: 829-840.
33. Silva MT (2010) When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J Leukoc Biol 87: 93-106.
34. Baldari CT, Tonello F, Paccani SR, Montecucco C (2006) Anthrax toxins: A paradigm of bacterial immune suppression. Trends Immunol 27: 434-440.
35. Boyden ED, Dietrich WF (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 38: 240-244.
36. Tschopp J, Martinon F, Burns K (2003) NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4: 95-104.
37. Ha SD, Ng D, Lamothe J, Valvano MA, Han J, et al. (2007) Mitochondrial proteins Bnip3 and Bnip3L are involved in anthrax lethal toxin-induced macrophage cell death. J Biol Chem 282: 26275-26283.
38. Alileche A, Serfass ER, Muehlbauer SM, Porcelli SA, Brojatsch J (2005) Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response. PLoS Pathog 1: e19.
39. Kau JH, Sun DS, Tsai WJ, Shyu HF, Huang HH, et al. (2005) Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets. J Infect Dis 192: 1465-1474.
40. Cheng CL, Sun DS, Chu WC, Tseng YH, Ho HC, et al. (2009) The effects of the bacterial interaction with visible-light responsive titania photocatalyst on the bactericidal performance. J Biomed Sci 16: 7.
41. Wong MS, Sun DS, Chang HH (2010) Bactericidal performance of visible-light responsive titania photocatalyst with silver nanostructures. PLoS One 5: e10394.
42. Chang HH, Kau JH, Lo SJ, Sun DS (2003) Cell-adhesion and morphological changes are not sufficient to support anchorage-dependent cell growth via nonintegrin-mediated attachment. Cell Biol Int 27: 123-133.
43. Chang HH, Shyu HF, Wang YM, Sun DS, Shyu RH, et al. (2002) Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J Infect Dis 186: 743-751.
44. Ortega-Barria E, Pereira ME (1991) A novel T. cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells. Cell 67: 411-421.
45. Chang HH, Lo SJ (2000) Modification with a phosphorylation tag of PKA in the TraT-based display vector of Escherichia coli. J Biotechnol 78: 115-122.
46. Liao G, Simone J, Simon SR (1994) Paracrine downregulation of Fc gamma RIII in human monocyte-derived macrophages induced by phagocytosis of nonopsonized particles. Blood 83: 2294-2304.
47. Huang HS, Sun DS, Lien TS, Chang HH (2010) Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice. Blood: In press.
48. Sun DS, King CC, Huang HS, Shih YL, Lee CC, et al. (2007) Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost 5: 2291-2299.
49. Wigelsworth DJ, Krantz BA, Christensen KA, Lacy DB, Juris SJ, et al. (2004) Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J Biol Chem 279: 23349-23356.
50. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184: 39-51.
51. Wong MS, Chu WC, Sun DS, Huang HS, Chen JH, et al. (2006) Visible-lightinduced bactericidal activity of a nitrogen-doped titanium photocatalyst against human pathogens. Appl Environ Microbiol 72: 6111-6116.